THE EFFECTS OF CARBIDOPA DOSE AND TIME AND ROUTE OF ADMINISTRATION ON SYSTEMIC L-DOPA LEVELS IN RATS

被引：25

作者：

LEPPERT, PS

CORTESE, M

FIX, JA

机构：

来源：

PHARMACEUTICAL RESEARCH | 1988年 / 5卷 / 09期

关键词：

D O I：

10.1023/A:1015946114321

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

页码：587 / 591

页数：5

共 19 条

[1]

BIANCHINE JR, 1973, ADV NEUROL, V2, P101

[2] INTERACTION OF L-ALPHA-METHYL-ALPHA-HYDRAZINO-3,4 DIHYDROXYPHENYLPROPIONIC ACID WITH DOPA-DECARBOXYLASE FROM PIG KIDNEY [J].

BORRIVOLTATTORNI, C ;

MINELLI, A ;

BORRI, P .

FEBS LETTERS, 1977, 75 (01) :277-280

[3] EFFECT OF SUPPLEMENTAL CARBIDOPA ON BIOAVAILABILITY OF L-DOPA [J].

CEDARBAUM, JM ;

KUTT, H ;

DHAR, AK ;

WATKINS, S ;

MCDOWELL, FH .

CLINICAL NEUROPHARMACOLOGY, 1986, 9 (02) :153-159

[4] BLOOD-BRAIN BARRIER TO CARBIDOPA (MK-486) AND RO4-4602, PERIPHERAL DOPA DECARBOXYLASE INHIBITORS [J].

CLARK, WG ;

OLDENDORF, WH ;

DEWHURST, WG .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1973, 25 (05) :416-418

[5]

DAVIS VE, 1960, J BIOL CHEM, V235, P124

[6]

FREUND JE, 1962, MATH STATISTICS

[7]

Jaffe ME, 1973, ADV NEUROL, V2, P161

[8]

KAAKKOLA S, 1985, ACTA NEUROL SCAND, V72, P385

[9] ANALYSIS OF THE CLINICAL PROBLEMS IN PARKINSONISM AND THE COMPLICATIONS OF LONG-TERM LEVODOPA THERAPY [J].

LESSER, RP ;

FAHN, S ;

SNIDER, SR ;

COTE, LJ ;

ISGREEN, WP ;

BARRETT, RE .

NEUROLOGY, 1979, 29 (09) :1253-1260

[10]

LOTTI VJ, 1970, J PHARMACOL EXP THER, V172, P406

← 1 2 →